{"title":"Особливості перебігу раку грудної залози з низьким рівнем експресії HER2/neu","authors":"","doi":"10.32471/clinicaloncology.2663-466x.50-2.30634","DOIUrl":null,"url":null,"abstract":"early disease stages. It was determined that the frequency of BC recurrences was higher in patients with greater HER2 expression, but it was not statistically significant, p >0.05. Conclusions. The obtained results propose general concepts of HER2-low BC and require further study","PeriodicalId":487505,"journal":{"name":"Клиническая онкология","volume":"64 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Клиническая онкология","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32471/clinicaloncology.2663-466x.50-2.30634","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
early disease stages. It was determined that the frequency of BC recurrences was higher in patients with greater HER2 expression, but it was not statistically significant, p >0.05. Conclusions. The obtained results propose general concepts of HER2-low BC and require further study
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
